Shree Ganesh Remedies Share Price
701.25-33.35 (-4.54%)
+29.67% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
SGRL-BNSE
Shree Ganesh Remedies Share Price
701.25-33.35 (-4.54%)
+29.67% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | 20% | 1% |
| - | - | 19% | -23% |
| - | 13% | 13% | 36% |
| 22% | 22% | 21% | 12% |
Peer Comparison
Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
ZYDUSLIFE-A
CIPLA-A
LAURUSLABS-A
MANKIND-A
DRREDDY-A
AUROPHARMA-A
LUPIN-A
SGRL-B
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,853 | ₹447476 Cr | 37 | 12.07 | 62.82 | ₹11479 Cr |
| 9,613 | ₹254764 Cr | 87.1 | 34.04 | 128.41 | ₹2568 Cr |
| 4,935 | ₹189423 Cr | 86.85 | 16.72 | 97.06 | ₹2163 Cr |
| 1,180 | ₹116658 Cr | 25.85 | 9.42 | 62.53 | ₹5040 Cr |
| 1,404 | ₹111484 Cr | 33.08 | 9.77 | 57.87 | ₹3879 Cr |
| 2,026.25 | ₹109943 Cr | 100.55 | 6.8 | 29.25 | ₹889 Cr |
| 2,475 | ₹101712 Cr | 49.79 | 13.75 | 71.08 | ₹1913 Cr |
| 1,200.4 | ₹101005 Cr | 31.35 | 5.32 | 63.99 | ₹4196 Cr |
| 1,720 | ₹99253 Cr | 26.73 | 17.95 | 96.84 | ₹3505 Cr |
| 2,098 | ₹96031 Cr | 17.37 | 30.95 | 154.35 | ₹5333 Cr |
| 701.25 | ₹943 Cr | 61.1 | 0.87 | 20.2 | ₹18 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| — | — | — | — | — |
| ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹9 Cr | ₹9 Cr |
| ₹150 Cr | ₹132 Cr | ₹109 Cr | ₹33 Cr | ₹25 Cr |
| ₹150 Cr | ₹132 Cr | ₹109 Cr | ₹33 Cr | ₹25 Cr |
| ₹163 Cr | ₹145 Cr | ₹122 Cr | ₹42 Cr | ₹34 Cr |
| ₹0 | ₹0 | ₹0 | ₹4 L | ₹0 |
| ₹21 Cr | ₹29 Cr | ₹29 Cr | ₹4 L | ₹24 L |
| ₹0 | ₹0 | ₹0 | ₹2 Cr | ₹0 |
| ₹1 Cr | ₹53 L | ₹58 L | ₹28 L | ₹33 L |
| ₹13 L | ₹13 L | ₹12 L | ₹0 | ₹0 |
| ₹57 L | ₹46 L | ₹33 L | ₹18 L | ₹16 L |
| ₹23 Cr | ₹31 Cr | ₹30 Cr | ₹3 Cr | ₹73 L |
| — | — | — | — | — |
| ₹9 Cr | ₹6 Cr | ₹8 Cr | ₹5 Cr | ₹4 Cr |
| ₹12 Cr | ₹10 Cr | ₹8 Cr | ₹20 L | ₹18 L |
| ₹2 L | ₹2 L | ₹71 L | ₹2 Cr | ₹33 L |
| ₹6 Cr | ₹8 Cr | ₹9 Cr | ₹4 Cr | ₹2 Cr |
| ₹27 Cr | ₹24 Cr | ₹26 Cr | ₹10 Cr | ₹7 Cr |
| ₹213 Cr | ₹200 Cr | ₹178 Cr | ₹55 Cr | ₹41 Cr |
| ₹2 Cr | ₹5 Cr | ₹5 Cr | ₹0 | ₹0 |
| ₹31 Cr | ₹38 Cr | ₹36 Cr | ₹4 Cr | ₹75 L |
| — | — | — | — | — |
| ₹148 Cr | ₹128 Cr | ₹105 Cr | ₹29 Cr | ₹21 Cr |
| ₹43 Cr | ₹33 Cr | ₹25 Cr | ₹9 Cr | ₹7 Cr |
| ₹105 Cr | ₹95 Cr | ₹81 Cr | ₹20 Cr | ₹14 Cr |
| ₹12 Cr | ₹8 Cr | ₹17 Cr | ₹0 | ₹0 |
| ₹8 L | ₹8 L | ₹8 L | ₹7 L | ₹5 L |
| ₹8 L | ₹8 L | ₹8 L | ₹7 L | ₹5 L |
| ₹4 Cr | ₹11 Cr | ₹3 Cr | ₹1 Cr | ₹72 L |
| ₹4 L | ₹20,000 | ₹50,000 | ₹20 L | ₹27 L |
| ₹122 Cr | ₹114 Cr | ₹101 Cr | ₹21 Cr | ₹16 Cr |
| — | — | — | — | — |
| ₹12 Cr | ₹18 Cr | ₹5 Cr | ₹3 Cr | ₹4 Cr |
| ₹24 Cr | ₹22 Cr | ₹25 Cr | ₹6 Cr | ₹7 Cr |
| ₹33 Cr | ₹22 Cr | ₹20 Cr | ₹18 Cr | ₹10 Cr |
| ₹13 Cr | ₹10 Cr | ₹16 Cr | ₹2 Cr | ₹100 L |
| ₹1 Cr | ₹1 Cr | ₹80 L | ₹0 | ₹0 |
| ₹7 Cr | ₹12 Cr | ₹10 Cr | ₹4 Cr | ₹5 Cr |
| ₹91 Cr | ₹86 Cr | ₹77 Cr | ₹34 Cr | ₹26 Cr |
| ₹64 Cr | ₹61 Cr | ₹52 Cr | ₹23 Cr | ₹19 Cr |
| ₹213 Cr | ₹200 Cr | ₹178 Cr | ₹55 Cr | ₹41 Cr |
| ₹127 | ₹113 | ₹95 | ₹47 | ₹38 |
| ₹127 | ₹113 | ₹95 | ₹35 | ₹28 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| ₹24 Cr | ₹31 Cr | ₹38 Cr | ₹14 Cr | ₹9 Cr |
| ₹12 Cr | ₹11 Cr | ₹6 Cr | -₹4 Cr | -₹35 L |
| -₹7 Cr | -₹2 Cr | -₹5 Cr | -₹5 Cr | -₹14 Cr |
| ₹29 Cr | ₹41 Cr | ₹39 Cr | ₹5 Cr | -₹5 Cr |
| ₹24 Cr | ₹31 Cr | ₹30 Cr | ₹5 Cr | -₹5 Cr |
| -₹10 Cr | -₹36 Cr | -₹33 Cr | -₹3 Cr | -₹8 L |
| -₹12 Cr | -₹1 Cr | ₹10 Cr | -₹48 L | -₹18 L |
| ₹2 Cr | -₹6 Cr | ₹7 Cr | ₹1 Cr | -₹5 Cr |
| ₹10 Cr | ₹16 Cr | ₹9 Cr | ₹1 Cr | ₹6 Cr |
| ₹1 Cr | ₹18 L | -₹8 L | ₹0 | ₹0 |
| ₹13 Cr | ₹10 Cr | ₹16 Cr | ₹2 Cr | ₹99 L |
Fundamental Ratios
Consolidated
Standalone
Shree Ganesh Remedies Share Price
701.25-33.35 (-4.54%)
+29.67% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 5
Bearish signals: 1 out of 9 oscillators
RSI
58.05Buy
STOCH %K
63.07Neutral
MACD Level(12,26)
29.26Buy
Ultimate Oscillator
54.99Buy
Aroon Oscillator
54.00Buy
BOP
-0.39Sell
CCI
58.61Neutral
Williams %R
-36.93Neutral
Momentum
14.75Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 9
Bearish signals: 0 out of 9 moving averages
EMA 9
694.93Buy
SMA 9
689.69Buy
EMA 21
665.24Buy
SMA 21
660.06Buy
EMA 50
636.98Buy
SMA 50
624.48Buy
EMA 200
588.53Buy
SMA 200
544.61Buy
WMA 20
686.04Buy
Pivot
Pivot
Classic
Resistance 5
909.87
Resistance 4
864.87
Resistance 3
819.87
Resistance 2
774.87
Resistance 1
754.73
Pivot
729.87
Support 1
709.73
Support 2
684.87
Support 3
639.87
Support 4
594.87
Support 5
549.87
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Shree Ganesh Remedies Share Price
701.25-33.35 (-4.54%)
+29.67% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 72.84% | 72.84% | 72.80% | 72.80% | 72.80% | 72.80% |
| 0.00% | 0.00% | 0.00% | 0.01% | 0.01% | 0.01% |
| 0.52% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 26.64% | 27.16% | 27.20% | 27.19% | 27.19% | 27.19% |
Bulk & block deals
Name
Nilesh Mansukhbhai Patel
Madras Parameswaran Manoj Mahadev
Khyani Harshil
Nnm Securities Pvt Ltd
Girraj Kishor Agarwal (Huf)
Nnm Securities Pvt Ltd
Nnm Securities Pvt Ltd
Miker Financial Consultants Private Limited
Rikhav Securities Limited
Nnm Securities Pvt Ltd
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 16 Feb 2021 | Sell | 1.73 Cr | ₹218.70 | 78.97 K | Bulk | 0.61517 | BSE |
| 09 Nov 2020 | Purchase | 1.17 Cr | ₹140.46 | 83.65 K | Bulk | 0.651602 | BSE |
| 07 Oct 2019 | Purchase | 35.06 L | ₹68.75 | 51 K | Bulk | 0.397271 | BSE |
| 07 Oct 2019 | Sell | 35.06 L | ₹68.75 | 51 K | Bulk | 0.397271 | BSE |
| 27 Mar 2019 | Purchase | 53.76 L | ₹68.92 | 78 K | Bulk | 0.60759 | BSE |
| 27 Mar 2019 | Purchase | 1.74 L | ₹58 | 3 K | Bulk | 0.023369 | BSE |
| 27 Mar 2019 | Sell | 55.61 L | ₹68.65 | 81 K | Bulk | 0.630959 | BSE |
| 06 Feb 2019 | Purchase | 23 L | ₹51.10 | 45 K | Bulk | 0.350533 | BSE |
| 15 Jan 2019 | Sell | 23.04 L | ₹51.20 | 45 K | Bulk | 0.350533 | BSE |
| 31 Dec 2018 | Purchase | 27.36 L | ₹50.66 | 54 K | Bulk | 0.420639 | BSE |
Insider trading & SAST
Client name
Chandrakant Koladiya
Chandrakant Koladiya
Chandrakant Koladiya
Parth Chandulal Kothia
Chandrakant Koladiya
Chandrakant Koladiya
Chandrakant Koladiya
Parth Chandulal Kothia
Chandrakant Koladiya
Chandrakant Koladiya
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20 Feb 2026 | Promoters Immediate Relative | Acquisition | 0.015579 | 0.12 | 10.14 L | ₹507.24 | 2 K | 16 Feb 2026 | Market Purchase | 15,534 | Insider Trading | — | Equity Shares |
| 16 Feb 2026 | Promoters Immediate Relative | Acquisition | 0.010991 | 0.1 | 7.15 L | ₹506.46 | 1.41 K | 11 Feb 2026 | Market Purchase | 12,333 | Insider Trading | — | Equity Shares |
| 16 Feb 2026 | Promoters Immediate Relative | Acquisition | 0.009355 | 0.11 | 6.17 L | ₹513.52 | 1.20 K | 13 Feb 2026 | Market Purchase | 13,534 | Insider Trading | — | Equity Shares |
| 16 Feb 2026 | Promoter | Acquisition | 0.006029 | 1.06 | 4 L | ₹516.54 | 774 | 13 Feb 2026 | Market Purchase | 1,36,689 | Insider Trading | — | Equity Shares |
| 11 Feb 2026 | Promoters Immediate Relative | Acquisition | 0.010913 | 0.09 | 7.01 L | ₹500.21 | 1.40 K | 10 Feb 2026 | Market Purchase | 10,922 | Insider Trading | — | Equity Shares |
| 11 Feb 2026 | Promoters Immediate Relative | Acquisition | 0.006232 | 0.07 | 3.72 L | ₹464.91 | 800 | 06 Feb 2026 | Market Purchase | 8,521 | Insider Trading | — | Equity Shares |
| 11 Feb 2026 | Promoters Immediate Relative | Acquisition | 0.00779 | 0.07 | 4.80 L | ₹479.89 | 1 K | 09 Feb 2026 | Market Purchase | 9,521 | Insider Trading | — | Equity Shares |
| 09 Feb 2026 | Promoter | Acquisition | 0.022348 | 1.06 | 13.06 L | ₹455.19 | 2.87 K | 05 Feb 2026 - 09 Feb 2026 | Market Purchase | 1,35,915 | Insider Trading | — | Equity Shares |
| 09 Feb 2026 | Promoters Immediate Relative | Acquisition | 0.00779 | 0.06 | 4.53 L | ₹452.86 | 1 K | 05 Feb 2026 | Market Purchase | 7,721 | Insider Trading | — | Equity Shares |
| 05 Feb 2026 | Promoters Immediate Relative | Acquisition | 0.012518 | 0.04 | 7.11 L | ₹442.61 | 1.61 K | 02 Feb 2026 | Market Purchase | 6,721 | Insider Trading | — | Equity Shares |
Shree Ganesh Remedies Share Price
701.25-33.35 (-4.54%)
+29.67% past 1 Year
Shree Ganesh Remedies is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. The company manufactures products relating to
Corporate Actions
Date
Type
Details
Company details
Shree Ganesh Remedies Share Price
701.25-33.35 (-4.54%)
+29.67% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Shree Ganesh Remedies Share Price
701.25-33.35 (-4.54%)
+29.67% past 1 Year
News
Shree Ganesh Remed. - Quaterly Results
Equity
SGRL
Shree Ganesh Remedies informs about outcome of board meeting
Equity
SGRL
Shree Ganesh Remed. reports Profit after tax of 6.27 Crores, in the March 2026 quarter
Equity
SGRL
Shree Ganesh Remed. - Quaterly Results
Equity
SGRL
Shree Ganesh Remedies informs about outcome of board meeting
Equity
SGRL
Shree Ganesh Remed. reports Profit after tax of 3.10 Crores, in the December 2025 quarter
Equity
SGRL
Shree Ganesh Remed. - Quaterly Results
Equity
SGRL
Shree Ganesh Remed. reports Profit after tax of 4.96 Crores, in the September 2025 quarter
Equity
SGRL
Shree Ganesh Remedies informs about outcome of board meeting
Equity
SGRL
Shree Ganesh Remed. - Quaterly Results
Equity
SGRL
Shree Ganesh Remed. - Quaterly Results
Equity
SGRL
Shree Ganesh Remed. reports Profit after tax of 3.45 Crores, in the June 2025 quarter
Equity
SGRL
Shree Ganesh Remed. - Quaterly Results
Equity
SGRL
Shree Ganesh Remed. - Quaterly Results
Equity
SGRL
Shree Ganesh Remed. reports Profit after tax of 6.60 Crores, in the March 2025 quarter
Equity
SGRL
Shree Ganesh Remed. - Quaterly Results
Equity
SGRL
Shree Ganesh Remed. - Quaterly Results
Equity
SGRL
Shree Ganesh Remedies informs about updates
Equity
SGRL
Shree Ganesh Remedies commissions 2.5 MW Solar Power Project
Equity
SGRL
Shree Ganesh Remedies informs about outcome of board meeting
Equity
SGRL

